Updates

Eagle Eye

December 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Having hit £3 last year, Eagle Eye has come off the boil on the suspicion that another fund raising is inevitable. Results for the year to 30 June were dubbed a “breakout year” with a key highlight being the successful launch of the PC Optimum loyalty programme for Canada's largest retail group, Loblaw, using the Eagle Eye Air platform. To date, Loblaw has attracted 14m customers to the scheme.PC Optimum allows Loblaw to run the digital equivalent of their paper-based coupon campaigns. This enables them to manage the issuance and redemption of digital promotions and rewards.Eagle Eye received a fee for implementation. Now hosting fees as well as transaction revenue from issuance of promotions and also a ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Altitude - Latest traction data showing real jump off in revenue

Alliance Pharma

Eagle Eye (February 2023)

Eagle Eye - Wins further North American business (March 2022)

Eagle Eye (April 2021)

Eagle Eye (October 2020)

Eagle Eye (December 2019)

Eagle Eye - Moves to EBITDA profitability (August 2019)

Eagle Eye - Shares well off the 316p high; 72% recurring fees (June 2019)

Eagle Eye - Positive EBITDA expected for H2 (April 2019)

Eagle Eye (August 2017)

Eagle Eye (July 2017)

Eagle Eye - Strong momentum with tier 1 retailers continues (June 2017)

Eagle Eye - Coupon redemption volumes rise to 4m a month in February (May 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X